Trending...
- Stockdale Capital Announces Four New Major Hires
- High-Growth Power Infrastructure Play Targets AI Boom: 1606 Corp. Executes Aggressive Texas Expansion Strategy: 1606 Corp. (Stock Symbol: CBDW) $CBDW
- As AI Accelerates Software Delivery, ThinkSys Introduces Zero Critical Bugs Guarantee
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that in the last twelve months, the United States Patent and Trademark Office has granted eight patents and allowed four patent applications related to the company's sacral neuromodulation technology.
The patents and allowed applications are part of Axonics' patent portfolio and represents technology internally developed by the company covering a range of subject matter that includes the Axonics external trial system, tined lead, implantable neurostimulator, clinician programmer, wireless charging system and patient remote control.
The granted U.S. patents are numbered: 11,083,903; 11,110,283; 11,116,985; 11,123,569; 11,213,675; 11,260,236; 11,389,659; and D952,859. The allowed U.S. patent applications are numbered: 16/547,324; 16/871,738; 16/913,532; and 16/882,295.
"Axonics is committed to developing best-in-class technology to serve the unmet needs of the millions of adults suffering from incontinence. The volume, subject matter diversity, and breadth of these patents demonstrate the investment in innovation that Axonics continues to make in sacral neuromodulation technology," said Raymond W. Cohen, chief executive officer.
More on The Californer
About Axonics
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
Axonics sacral neuromodulation (SNM) systems provide adults suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company's best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.
More on The Californer
Contacts
Neil Bhalodkar
949-336-5293
ir@axonics.com
The patents and allowed applications are part of Axonics' patent portfolio and represents technology internally developed by the company covering a range of subject matter that includes the Axonics external trial system, tined lead, implantable neurostimulator, clinician programmer, wireless charging system and patient remote control.
The granted U.S. patents are numbered: 11,083,903; 11,110,283; 11,116,985; 11,123,569; 11,213,675; 11,260,236; 11,389,659; and D952,859. The allowed U.S. patent applications are numbered: 16/547,324; 16/871,738; 16/913,532; and 16/882,295.
"Axonics is committed to developing best-in-class technology to serve the unmet needs of the millions of adults suffering from incontinence. The volume, subject matter diversity, and breadth of these patents demonstrate the investment in innovation that Axonics continues to make in sacral neuromodulation technology," said Raymond W. Cohen, chief executive officer.
More on The Californer
- New Dosio App Helps GLP-1 Users Track Shots, Side Effects, and Weight Trends
- Rachel Farris, CPA and Founder of Tax Stack AI, Featured on The Big 4 Transparency Podcast
- Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
- When the Wrong Word Can Cost Everything, You Need a Legal Translation Partner You Can Actually Trust
- News you won't see on Fox News: California revoked over 280 hospice licenses, 300 more providers under investigation since Governor Newsom's hospice moratorium
About Axonics
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
Axonics sacral neuromodulation (SNM) systems provide adults suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company's best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.
More on The Californer
- Colony Ridge Communities Celebrates Successful Soccer Season Kickoff with Families and Youth
- One Circle Foundation Launches Calm & Connected, a New Youth Mental Health Curriculum
- United Hotel Supply Rolls Out Upgraded PTAC & HVAC Solution for Hotels & Motels in the U.S
- Blackfoot Communications Expands Into New Rural Digital Opportunity Fund With netElastic vBNG and CGNAT Networking Software
- Colette Barris's Open Letter To Revolt's Detavio Samuels 'The BlackPrint' Interview Of Kenya Barris
Contacts
Neil Bhalodkar
949-336-5293
ir@axonics.com
Filed Under: Business
0 Comments
Latest on The Californer
- Breaking the Civilian Barrier: ResuModAI Helps Veterans Translate Military Service into Job Offers in 60 Seconds
- Global Leaders Meet in Baku: The World Is Running Out of Time
- Long Beach Parks, Recreation and Marine to Offer Youth Summer Day Camps
- USFITC Extends International Defense Supply Capabilities with Sealing Component Delivery
- Supply & Demand Chain Executive Names Puga Sankara as Recipient of 2026 Pros to Know Award
- For Financial Literacy Month: Check out "TINA, TARA, TAPAS & TIARA" & "Better Than Expected Losses"
- Benchmark International Successfully Facilitated the Transaction Between LPAS, Inc. and Bluwatr
- TIME WASTED: The 2027 Releasing TV Show
- JetPipe Plumbing Brings Licensed, Specialized Plumbing Services to the San Francisco Bay Area
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
- A-One Janitorial Wins $152M AI Campus Contract — Meta, Microsoft, Google, and AWS
- New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
- Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
- Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
- Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry
- NEW MANAGEMENT BOOK: Creating a Joy-Centric Culture
- Countrywide Rental Strengthens Waste Management Services Across Bankston Campuses
- Burbank Startup XBYZ LLC Launches Full-Service Business Platform for California Entrepreneurs
- Official Statement On The Passing Of KiKi Shepard From The Shepard Family